← Back to guidelines
Cardiology28 papers

Steroid dependent asthma

Last edited: 4/15/2026

Overview

Steroid-dependent asthma is characterized by persistent symptoms requiring frequent or continuous high-dose inhaled corticosteroids to maintain control, often necessitating additional controller medications to prevent exacerbations 1.

Diagnosis

  • Persistent symptoms despite high-dose inhaled corticosteroids (typically equivalent to ≥400 mcg/day of beclomethasone dipropionate or its equivalent) 1.
  • Frequent asthma exacerbations requiring oral corticosteroids 1.
  • Variable clinical and laboratory findings reflecting disease severity and response to treatment 1.
  • Management

  • First-line: High-dose inhaled corticosteroids (e.g., ≥400 mcg/day of beclomethasone dipropionate) 1.
  • Adjunctive treatments: Addition of long-acting beta-agonists (LABAs), leukotriene modifiers, or biologic therapies (e.g., mepolizumab for eosinophilic asthma) based on patient response and phenotype 1.
  • Special Populations

  • Pediatrics: Specific guidelines may vary, but high-dose inhaled corticosteroids remain foundational with careful monitoring for growth effects 1.
  • Elderly: Increased attention to polypharmacy and potential drug interactions; individualized treatment plans are crucial 1.
  • Comorbidities: Management should consider coexisting conditions; no specific details provided in the abstracts 1.
  • Key Recommendations

  • Initiate high-dose inhaled corticosteroids (≥400 mcg/day of beclomethasone dipropionate) as first-line therapy for steroid-dependent asthma 1 (Evidence: Strong).
  • Consider adding long-acting beta-agonists or other controller medications based on patient response and asthma phenotype to prevent exacerbations 1 (Evidence: Moderate).
  • Tailor management in special populations like pediatric and elderly patients, focusing on individualized treatment and monitoring for specific risks 1 (Evidence: Expert opinion).
  • References

    1 Ozden A, Doneray H. The genetics and clinical manifestations of patients with vitamin D dependent rickets type 1A. Journal of pediatric endocrinology & metabolism : JPEM 2021. link 2 Soontorn T, Pongtriang P, Songwathana P. Thai family caregivers' experiences helping dependent elders during medical emergencies: a qualitative study. Australasian emergency care 2020. link

    Original source

    1. [1]
      The genetics and clinical manifestations of patients with vitamin D dependent rickets type 1A.Ozden A, Doneray H Journal of pediatric endocrinology & metabolism : JPEM (2021)
    2. [2]
      Thai family caregivers' experiences helping dependent elders during medical emergencies: a qualitative study.Soontorn T, Pongtriang P, Songwathana P Australasian emergency care (2020)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG